Major depressive disorder impacts a significant portion of the world’s population—many of whom struggle to access adequate mental healthcare. Digital therapeutics offer a robust, evidence-based opportunity to bridge access gaps in care, with the potential to positively affect the lives of those with major depressive disorder and other mental health disorders.
Slides from the digital therapeutics presentation at the 9th Annual Mood Disorders Summit 2022
Watch this on-demand webcast of a live CCO presentation on the current and emerging digital strategies for major depressive disorder with a focus on digital therapeutic interventions that can potentially improve treatments for patients with MDD.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.